Johnson & Johnson ACUVUE Theravision with Ketotifen (etafilcon A drug-eluting contact lens with ketotifen) - HSA Registration DE0507617
Access comprehensive regulatory information for Johnson & Johnson ACUVUE Theravision with Ketotifen (etafilcon A drug-eluting contact lens with ketotifen) in the Singapore medical device market through Pure Global AI's free database. This CLASS COM medical device is registered under HSA registration number DE0507617 and owned by Johnson & Johnson Vision Care, Inc.. The device was registered on December 19, 2022.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
ACUVUE Theravision with Ketotifen are daily wear, daily disposable drug-eluting contact lenses containing an antihistamine to prevent ocular itch due to allergic conjunctivitis and correction of refractive ametropia (myopia and hyperopia) in patients who do not have red eye(s), are suitable for contact lens wear and do not have more than 1.00 D of astigmatism. Itchy eye prevention has been demonstrated to last up to 12 hours in clinical trials; however, the lens may be worn for longer than 12 hours for vision correction.

